Karl Pfleger, an angel investor and creator of Aging Biotech Info, dives into the exciting world of rejuvenation biotechnology. He shares insights on the rapid advancements in the field, including breakthroughs in epigenetic reprogramming and stem cell therapies. Karl discusses the role of AI in streamlining clinical trials and the importance of investors in combating age-related diseases. He also explores the concept of longevity escape velocity and how individuals can contribute to this innovative sector.

Karl Pfleger, a Super Angel in longevity, shares his journey from AI to biotech investing. Topics include advancements in aging biology, challenges in biotech startups, advocacy space growth, building a biotech database, exploring aging drugs, and rejuvenation therapies for longevity.